Phase 2/3 biotech targeting the novel HGF/MET pathway for Alzheimer's.
Industry: Health Care
First Day Return: +0.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/26/2020 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 12.0 |
Deal Size ($mm) | $204 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/17/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $204 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Seattle, WA, United States |
Founded | 2011 |
Employees at IPO | 15 |
Website www.athira.com |